SCHEMBL9181985

SCHEMBL9181985

[O]C(c1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.55
ESR2 Q92731 8/20 0.55
PDCD1 Q15116 1/20 0.52
CD274 Q9NZQ7 1/20 0.52
ALOX15 P16050 4/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 3/20 0.50
CYP3A4 P08684 2/20 0.50
NFKB1 P19838 2/20 0.50
HIF1A Q16665 2/20 0.50
KDM4E B2RXH2 2/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 1/20 0.50
NPC1 O15118 1/20 0.50
CA12 O43570 1/20 0.50
GMNN O75496 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA3 P07451 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10628645 0.77 ESR1 (0.62) ESR1ESR2PDCD1CD274ALOX15
SCHEMBL5709283 0.75 ESR1 (0.55) ESR1ESR2PDCD1CD274ALOX15
SCHEMBL7300588 0.75 ESR1 (0.55) ESR1ESR2PDCD1CD274ALOX15
SCHEMBL31274990 0.73 ESR1 (0.58) ESR1ESR2PDCD1CD274ALOX15
SCHEMBL40254 0.73 ESR1 (0.58) ESR1ESR2PDCD1CD274ALOX15
SCHEMBL216712 0.73 ESR1 (0.58) ESR1ESR2PDCD1CD274ALOX15
SCHEMBL133408 0.73 ESR1 (0.58) ESR1ESR2PDCD1CD274ALOX15
SCHEMBL118557 0.71 ESR1 (0.55) ESR1ESR2PDCD1CD274ALOX15
Methane SCHEMBL7206625 0.71 ESR1 (0.55) ESR1ESR2PDCD1CD274ALOX15
Bis(4-Hydroxyphenyl)Methanol SCHEMBL3642317 0.71 CYP3A4 (0.62) ESR1ESR2PDCD1CD274ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed